DNA Hypomethylation-Related Overexpression of SFN, GORASP2 and ZYG11A Is a Novel Prognostic Biomarker for Early Stage Lung Adenocarcinoma

Oncotarget - United States
doi 10.18632/oncotarget.26676
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Trans-Omics Biomarker Model Improves Prognostic Prediction Accuracy for Early-Stage Lung Adenocarcinoma

Aging
AgingCell Biology
2019English

A Multigene Assay Is Prognostic of Survival in Patients With Early-Stage Lung Adenocarcinoma

Clinical Cancer Research
Cancer ResearchOncology
2008English

2394 Sodium-Glucose Transporter 2 Is a Novel Diagnostic and Therapeutic Target for Early-Stage Lung Adenocarcinoma

Journal of Clinical and Translational Science
Medicine
2018English

P2.02-067 LKB1 Loss Is Associated With DNA Hypomethylation in Human Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Mesothelin Overexpression Is a Marker of Tumor Aggressiveness and Is Associated With Reduced Recurrence-Free and Overall Survival in Early-Stage Lung Adenocarcinoma

Clinical Cancer Research
Cancer ResearchOncology
2013English

MicroRNA-374a Expression as a Prognostic Biomarker in Lung Adenocarcinoma

Journal of Pathology and Translational Medicine
Forensic MedicinePathologyHistology
2019English

LAPTM4B Is a Novel Diagnostic and Prognostic Marker for Lung Adenocarcinoma and Associated With Mutant EGFR

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Molecular Prognostic Factors in Early-Stage Cervical Adenocarcinoma

Polish Journal of Pathology
MedicineForensic MedicinePathology
2018English

Identification of a Sixteen-Gene Prognostic Biomarker for Lung Adenocarcinoma Using a Machine Learning Method

Journal of Cancer
Oncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy